Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-03-24
2009-12-01
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253040, C514S253090, C514S254050, C544S357000, C544S362000, C544S364000, C544S368000, C544S370000
Reexamination Certificate
active
07625902
ABSTRACT:
The invention is concerned with novel imidazolidinone derivatives of formula (I):wherein R1to R11and X are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds bind to LXR alpha and LXR beta and can be used in pharmaceutical compositions.
REFERENCES:
patent: 2006/0004068 (2006-01-01), Dehmlow et al.
patent: WO 00/54759 (2000-09-01), None
patent: WO 01/60818 (2001-08-01), None
patent: WO 02/24632 (2002-03-01), None
patent: WO 03/099769 (2003-12-01), None
Lund et al., Arterioscler. Thromb. Vasc. Biol. 23, pp. 1169-1177 (2003).
Mitro et al., Nature, 445, pp. 219-223 (2007).
Joseph et al., Curr. Opin. Pharmacol., 3, pp. 192-197 (2003).
Cao et al., J. Biol. Chem., 278, pp. 1131-1136 (2003).
Nadir et al., J. Heterocyclic Chem., 41, pp. 737-739 (2004).
Dehmlow Henrietta
Kuhn Bernd
Obst Sander Ulrike
Roever Stephan
Schulz-Gasch Tanja
Bernhardt Emily
Hoffmann-La Roche Inc.
Johnston George W.
Remy Brian C.
Tramaloni Dennis P.
LandOfFree
Imidazolidinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolidinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolidinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4139991